Company news
Neovasc Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
July 13, 2021
Largest Real-World Registry Supporting Neovasc Reducer(TM) Safety and Efficacy Outcomes Published in International Journal of Cardiology
June 18, 2021
Neovasc Provides Corporate Update
June 10, 2021
Neovasc Reducer System Receives First National Reimbursement in Europe
June 7, 2021
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
June 3, 2021
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
May 25, 2021
Neovasc Provides Update on German Litigation
May 20, 2021
Neovasc to Sponsor Symposium on Reducer at EuroPCR
May 13, 2021
Neovasc Announces First Patient Enrollment in COSIMA Trial
May 10, 2021
Neovasc Announces First Quarter 2021 Financial Results
May 6, 2021
Neovasc Provides Reducer Reimbursement Progress Update
April 28, 2021
Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021
April 27, 2021
Neovasc Comments on EuroIntervention Article
April 19, 2021
Neovasc Provides Tiara TA Update
April 16, 2021
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
March 11, 2021
Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021
March 4, 2021
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
March 3, 2021
Neovasc Comments on Clinical Cardiology Journal Publication
March 2, 2021
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
February 24, 2021
Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
February 17, 2021
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
February 12, 2021
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
February 10, 2021
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
February 9, 2021
Neovasc Comments on Journal of the American Heart Association Publication
February 5, 2021
Neovasc Announces 2021 Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina
February 2, 2021
American Medical Association Issues New CPT Code for Neovasc Reducer Procedure
January 29, 2021
Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
January 19, 2021
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer(TM)
January 15, 2021
Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
January 4, 2021
Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
December 17, 2020
Neovasc Announces First Neovasc Reducer(TM) Implants in France
December 15, 2020
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
December 14, 2020
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
December 10, 2020
Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-The-Market
December 10, 2020
Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market
December 8, 2020
Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series
December 1, 2020
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
November 16, 2020
Neovasc Announces Third Quarter Financial Results
November 5, 2020
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina
October 28, 2020
Neovasc to Report Third Quarter Financial Results on November 5, 2020
October 22, 2020
Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020
October 13, 2020
Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference
September 8, 2020
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
September 3, 2020
Neovasc Announces Partial Prepayment of Convertible Debenture
August 17, 2020
Neovasc Provides Corporate Update
August 13, 2020
Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market
August 12, 2020
Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market
August 10, 2020
Neovasc Announces Second Quarter Financial Results
August 6, 2020
Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper
July 24, 2020
Neovasc Announces Partial Prepayment of Convertible Debenture
July 23, 2020
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- EuroPCR 2020
Conference · 11 slides · June 2020
- Investor Presentation (January 2015)
Investor deck · 22 slides · January 2015
- Investor Presentation (November 2014)
Investor deck · 23 slides · November 2014
- Investor Presentation (April 2013)
Investor deck · 19 slides · April 2013
- Investor Presentation (May 2012)
Investor deck · 21 slides · May 2012